These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


334 related items for PubMed ID: 3871412

  • 1. Corticotropin-releasing factor and behavior.
    Koob GF, Bloom FE.
    Fed Proc; 1985 Jan; 44(1 Pt 2):259-63. PubMed ID: 3871412
    [Abstract] [Full Text] [Related]

  • 2. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF, Thatcher-Britton K.
    Prog Clin Biol Res; 1985 Jan; 192():499-506. PubMed ID: 3878524
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiological actions of corticotropin-releasing factor in the central nervous system.
    Siggins GR, Gruol D, Aldenhoff J, Pittman Q.
    Fed Proc; 1985 Jan; 44(1 Pt 2):237-42. PubMed ID: 3155696
    [Abstract] [Full Text] [Related]

  • 4. Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures.
    Blatchford KE, Choi EA, McNally GP.
    Behav Neurosci; 2006 Oct; 120(5):1169-74. PubMed ID: 17014268
    [Abstract] [Full Text] [Related]

  • 5. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys.
    Kalin NH.
    Fed Proc; 1985 Jan; 44(1 Pt 2):249-53. PubMed ID: 3871411
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW, Duffy P, Latimer LG.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
    Erb S, Brown ZJ.
    Behav Brain Res; 2006 Sep 25; 172(2):360-4. PubMed ID: 16822557
    [Abstract] [Full Text] [Related]

  • 9. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.
    Ohmura Y, Yamaguchi T, Futami Y, Togashi H, Izumi T, Matsumoto M, Yoshida T, Yoshioka M.
    Behav Brain Res; 2009 Mar 17; 198(2):429-33. PubMed ID: 19084036
    [Abstract] [Full Text] [Related]

  • 10. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
    Salak-Johnson JL, Anderson DL, McGlone JJ.
    Physiol Behav; 2004 Oct 30; 83(1):143-50. PubMed ID: 15501501
    [Abstract] [Full Text] [Related]

  • 11. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
    Sajdyk TJ, Fitz SD, Shekhar A.
    Stress; 2006 Mar 30; 9(1):21-8. PubMed ID: 16753930
    [Abstract] [Full Text] [Related]

  • 12. Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats.
    De Sarro GB, Fratta W, Giglio A, Nisticò G.
    Funct Neurol; 1992 Mar 30; 7(5):407-12. PubMed ID: 1292962
    [Abstract] [Full Text] [Related]

  • 13. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C, Cordero MI, Ugolini A, Varea E, Caberlotto L, Large CH.
    Eur J Neurosci; 2008 Nov 30; 28(9):1836-48. PubMed ID: 18973598
    [Abstract] [Full Text] [Related]

  • 14. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
    Yang XM, Gorman AL, Dunn AJ.
    J Pharmacol Exp Ther; 1990 Dec 30; 255(3):1064-70. PubMed ID: 2262892
    [Abstract] [Full Text] [Related]

  • 15. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H, Shibasaki T.
    Peptides; 2004 Oct 30; 25(10):1703-9. PubMed ID: 15476937
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF.
    Psychopharmacology (Berl); 2002 Mar 30; 160(2):113-21. PubMed ID: 11875628
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats.
    Lowry CA, Hale MW, Plant A, Windle RJ, Shanks N, Wood SA, Ingram CD, Renner KJ, Lightman SL, Summers CH.
    Stress; 2009 May 30; 12(3):225-39. PubMed ID: 18951247
    [Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).
    Al Chawaf A, Xu K, Tan L, Vaccarino FJ, Lovejoy DA, Rotzinger S.
    Peptides; 2007 Jul 30; 28(7):1406-15. PubMed ID: 17644218
    [Abstract] [Full Text] [Related]

  • 19. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
    Erb S, Funk D, Lê AD.
    Neurosci Lett; 2005 Aug 05; 383(3):209-14. PubMed ID: 15955413
    [Abstract] [Full Text] [Related]

  • 20. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
    Zieba B, Grzegorzewska M, Brański P, Domin H, Wierońska JM, Hess G, Smiałowska M.
    Neuropeptides; 2008 Aug 05; 42(5-6):513-23. PubMed ID: 18617263
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.